A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics

被引:43
作者
Laurence, Caroline [1 ]
Gialamas, Angela [1 ]
Yelland, Lisa [2 ]
Bubner, Tanya [1 ]
Ryan, Philip [2 ]
Willson, Kristyn [2 ]
Glastonbury, Briony [4 ]
Gill, Janice [3 ]
Shephard, Mark [5 ]
Beilby, Justin [6 ]
机构
[1] Univ Adelaide, Discipline Gen Practice, Adelaide, SA, Australia
[2] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia
[3] RCPA Qual Assurance Programs Pty Ltd, Adelaide, SA, Australia
[4] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
[5] Flinders Univ S Australia, Rural Clin Sch, Community Point Of Care Serv, Adelaide, SA, Australia
[6] Univ Adelaide, Fac Hlth Sci, Adelaide, SA, Australia
关键词
D O I
10.1186/1745-6215-9-50
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Point of care testing (PoCT) may be a useful adjunct in the management of chronic conditions in general practice (GP). The provision of pathology test results at the time of the consultation could lead to enhanced clinical management, better health outcomes, greater convenience and satisfaction for patients and general practitioners (GPs), and savings in costs and time. It could also result in inappropriate testing, increased consultations and poor health outcomes resulting from inaccurate results. Currently there are very few randomised controlled trials (RCTs) in GP that have investigated these aspects of PoCT. Design/Methods: The Point of Care Testing in General Practice Trial (PoCT Trial) was an Australian Government funded multi-centre, cluster randomised controlled trial to determine the safety, clinical effectiveness, cost effectiveness and satisfaction of PoCT in a GP setting. The PoCT Trial covered an 18 month period with the intervention consisting of the use of PoCT for seven tests used in the management of patients with diabetes, hyperlipidaemia and patients on anticoagulant therapy. The primary outcome measure was the proportion of patients within target range, a measure of therapeutic control. In addition, the PoCT Trial investigated the safety of PoCT, impact of PoCT on patient compliance to medication, stakeholder satisfaction, cost effectiveness of PoCT versus laboratory testing, and influence of geographic location. Discussion: The paper provides an overview of the Trial Design, the rationale for the research methodology chosen and how the Trial was implemented in a GP environment. The evaluation protocol and data collection processes took into account the large number of patients, the broad range of practice types distributed over a large geographic area, and the inclusion of pathology test results from multiple pathology laboratories. The evaluation protocol developed reflects the complexity of the Trial setting, the Trial Design and the approach taken within the funding provided. The PoCT Trial is regarded as a pragmatic RCT, evaluating the effectiveness of implementing PoCT in GP and every effort was made to ensure that, in these circumstances, internal and external validity was maintained.
引用
收藏
页数:14
相关论文
共 52 条
[1]  
[Anonymous], EMJA
[2]  
*AUSTR GOV, 2004, STAND POINT CAR TEST
[3]   Patients' problems with new medication for chronic conditions [J].
Barber, N ;
Parsons, J ;
Clifford, S ;
Darracott, R ;
Horne, R .
QUALITY & SAFETY IN HEALTH CARE, 2004, 13 (03) :172-175
[4]   Immediate feedback of HbA1c levels improves glycemic control in type I and insulin-treated type 2 diabetic patients [J].
Cagliero, E ;
Levina, EV ;
Nathan, DM .
DIABETES CARE, 1999, 22 (11) :1785-1789
[5]   CONSORT statement: extension to cluster randomised trials [J].
Campbell, MK ;
Elbourne, DR ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441) :702-708
[6]   The belgian improvement study on oral anticoagulation therapy: a randomized clinical trial [J].
Claes, N ;
Buntinx, F ;
Vijgen, J ;
Arnout, J ;
Vermylen, J ;
Fieuws, S ;
Van Loon, H .
EUROPEAN HEART JOURNAL, 2005, 26 (20) :2159-2165
[7]   Estimating the cost-effectiveness of quality-improving interventions in oral anticoagulation management within general practice [J].
Claes, Neree ;
Moeremans, Karen ;
Buntinx, Frank ;
Arnout, Jef ;
Vermylen, Jos ;
Van Loon, Herman ;
Annemans, Lieven .
VALUE IN HEALTH, 2006, 9 (06) :369-376
[8]   Near-patient testing for serum cholesterol: attitudes of general practitioners and patients, appropriateness, and costs [J].
Cohen, J ;
Piterman, L ;
McCall, LM ;
Segal, L .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 168 (12) :605-609
[9]   Systematic review of near patient test evaluations in primary care [J].
Delaney, BC ;
Hyde, CJ ;
McManus, RJ ;
Wilson, S ;
Fitzmaurice, DA ;
Jowett, S ;
Tobias, R ;
Thorpe, GH ;
Hobbs, FDR .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7213) :824-827
[10]   Accuracy of a portable international normalization ratio monitor in outpatients receiving long-term oral anticoagulant therapy: Comparison with a laboratory reference standard using clinically relevant criteria for agreement [J].
Douketis, JD ;
Lane, A ;
Milne, J ;
Ginsberg, JS .
THROMBOSIS RESEARCH, 1998, 92 (01) :11-17